{"id":333542,"date":"2026-10-30T14:54:41","date_gmt":"2026-10-30T09:24:41","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=333542"},"modified":"2026-10-30T14:54:41","modified_gmt":"2026-10-30T09:24:41","slug":"global-generic-drug-maker-over-the-counter-medicines-exporter-and-isobutylene-derivatives-maker-stocks-roadmap-landmark-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/global-generic-drug-maker-over-the-counter-medicines-exporter-and-isobutylene-derivatives-maker-stocks-roadmap-landmark-list\/","title":{"rendered":"3 Global Generic Drug Maker, Over the Counter Medicines Exporter and Isobutylene Derivatives Maker Stocks With a Strong Future Roadmap: Dr. Reddy’s Laboratories, Marksans Pharma and Vinati Organics"},"content":{"rendered":"

Dr. Reddy’s Laboratories, Marksans Pharma and Vinati Organics: ROE of 11.1% to 14.0% and FY22 to FY26 revenue CAGR of 8.0% to 18.6%. Prices as of 29 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three generic drug, OTC and isobutylene stocks to watch are Dr. Reddy’s Laboratories, Marksans Pharma and Vinati Organics. Their return on equity ranges from 11.1% to 14.0%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.0% to 18.6%. Vinati Organics has the highest return on equity at 14.0%, while Marksans Pharma has the fastest revenue growth at 18.6% a year. Prices are based on the 29 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Generic drug, OTC and isobutylene stocks give investors a way to track businesses that sit close to everyday demand in India. Dr. Reddy’s Laboratories, Marksans Pharma and Vinati Organics cover a global generic drug maker, an over the counter medicines exporter and an isobutylene derivatives maker.<\/p>\n

This list covers three generic drug, OTC and isobutylene stocks with complete current figures: Dr. Reddy’s Laboratories, Marksans Pharma and Vinati Organics. Every figure comes from the latest reported financials and the 29 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n